title: Management of ascites in cirrhotic patients.
authors.affiliation: Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Kurosaki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nakanishi
authors.forename: Namiki
authors.initials: N
authors.lastname: Izumi
mesh_terms: D065092:Antidiuretic Hormone Receptor Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D051399:Aquaporin 2 / Q000378:metabolism; D001201:Ascites / Q000209:etiology* / Q000628:therapy*; D001552:Benzazepines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007564:Japan; D008103:Liver Cirrhosis / Q000150:complications*; D017410:Practice Guidelines as Topic; D017483:Receptors, Vasopressin / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use; D000077602:Tolvaptan; D014667:Vasopressins
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D051399:Aquaporin 2; D001552:Benzazepines; D004232:Diuretics; D017483:Receptors, Vasopressin; D049994:Sodium Potassium Chloride Symporter Inhibitors; D014667:Vasopressins; D000077602:Tolvaptan; D013148:Spironolactone